MICHAEL A. PIETRANGELO - Corporate Board Profile

UNIVERSAL INSURANCE HOLDINGS, INC.

Filing Date	Source Excerpt
2010-04-16	Effective March 26, 2010, the Company’s Board of Directors, in accordance with the Company’s charter and bylaws, expanded its size by one seat and appointed Michael A. Pietrangelo to the Company Board of Directors. Mr. Pietrangelo did not receive any compensation from the Company for the year ended December 31, 2009.
2011-04-08	Michael A. Pietrangelo has been a director of the Company since March 2010.
2012-04-30	Michael A. Pietrangelo has been a director of the Company since March 2010. Mr. Pietrangelo has practiced law at Pietrangelo Cook PLC since 1998 and is admitted to the New York, Tennessee and District of Columbia bars. He currently serves on the board of directors of Medicis Pharmaceutical Corporation, an independent specialty pharmaceutical company listed on the New York Stock Exchange ("NYSE") and the American Parkinson Disease Association, a not-for-profit organization focused on serving the Parkinson’s community. Mr. Pietrangelo currently serves as the managing partner of Theraplex Company LLC, a privately held company. Mr. Pietrangelo currently serves on the board of directors of Surgivision, Inc., a public company now known as MRI Interventions, Inc. From 1994 until 1998, Mr. Pietrangelo served as President of Johnson Products Company, a subsidiary of IVAX Corporation. From 1990 to 1994, Mr. Pietrangelo was the President and Chief Executive Officer of CLEO, Inc., a subsidiary of Gibson Greetings, Inc. and manufacturer of specialized paper products. From 1967 to 1989, he served in a variety of legal and management roles at the Federal Trade Commission, Pfizer, Inc., Schering-Plough Corporation and Western Publishing Group. Mr. Pietrangelo has valuable experience in corporate governance, legal and financial matters as a result of his participation as a lawyer, executive and director of privately held and public companies as well as non-profit organizations. This experience gives him perspective and knowledge as a member of our Board.
2013-04-24	Michael A. Pietrangelo has been a director of the Company since March 2010. Mr. Pietrangelo has valuable experience in corporate governance, legal and financial matters.
2014-04-23	Michael A. Pietrangelo has been a director of the Company since March 2010. ... The Compensation Committee consists of Reed J. Slogoff, Darryl L. Lewis and Michael A. Pietrangelo. ... The Nominating and Governance Committee, whose members are Scott P. Callahan, Michael A. Pietrangelo and Joel M. Wilentz, M.D.
2015-04-15	Michael A. Pietrangelo has been a director of the Company since 2010. ... The Compensation Committee consists of Darryl L. Lewis, Richard D. Peterson and Michael A. Pietrangelo, each of whom was determined by the Board to be independent under the applicable rules of the SEC and NYSE. Mr. Lewis serves as chairman of the Compensation Committee. ... The Nominating and Governance Committee members are Scott P. Callahan, Michael A. Pietrangelo and Joel M. Wilentz, M.D., each of whom was determined by the Board to be independent under the applicable rules of the SEC and NYSE. Mr. Pietrangelo serves as chairman of the Nominating and Governance Committee. ... Director Summary Compensation Table: Michael A. Pietrangelo Fees Earned or Paid in Cash ($) 100,000, Option Awards ($) 47,565, Total ($) 147,565.
2016-04-29	Michael A. Pietrangelo became a director of the Company in 2010. Since 1998, Mr. Pietrangelo has practiced law and has been of counsel to the firm of Pietrangelo Cook, PLC. Mr. Pietrangelo is admitted to the bars of the states of New York and Tennessee and the District of Columbia. He served on the board of directors of MRI Interventions Inc., a publicly traded research and development company, from 2010 to 2014, and he currently serves on the board of directors of the American Parkinson Disease Association, a not-for-profit organization focused on serving the Parkinson's community. Mr. Pietrangelo also serves as the managing partner of The Theraplex Company, LLC, a privately held skin care company. He has valuable experience in corporate governance, legal and financial matters as a result of his positions as a lawyer, executive and director of privately held and public companies, as well as nonprofit organizations. Director Summary Compensation Table shows $100,000 fees paid in cash in 2015.
2017-04-28	Michael A. Pietrangelo (Lead Independent Director) 74 2010 Lawyer with Pietrangelo Cook, PLC Nominating & Governance Committee member, Compensation Committee Chair, Audit Committee member, Director compensation $213,872
2018-04-27	Michael A. Pietrangelo (Lead Independent Director) 75 2010 Lawyer with Pietrangelo Cook, PLC Nominating & Governance Committee member and Lead Director, Investment Committee member, Compensation Committee Chair
2019-04-29	Michael A. Pietrangelobecame a director of the Company in 2010. Since 1998, Mr. Pietrangelo has practiced law and has been of counsel to the firm of Pietrangelo Cook, PLC. Mr. Pietrangelo is admitted to the bars of the states of New York and Tennessee and the District of Columbia. He served on the board of directors of MRI Interventions Inc., a publicly traded research and development company, from 2010 to 2014, and he currently serves on the board of directors of the American Parkinson Disease Association, a not-for-profit organization focused on serving the Parkinson9s community. Mr. Pietrangelo also serves as the managing partner of The Theraplex Company, LLC, a privately held skin care company. He brings valuable experience to the Board in corporate governance, legal and financial matters as a result of his positions as a lawyer, executive and director of privately held and public companies, as well as nonprofit organizations.
2020-04-29	Michael A. Pietrangelo (Lead Independent Director) 77 2010 President and Managing Director of The Theraplex Company, LLC. Member of Investment Committee, Chair of Compensation Committee and Audit Committee. Total compensation $298,037.
2021-04-29	Michael A. Pietrangelo 78 2010 President and Managing Director of The Theraplex Company, LLC. Committees: Member of Nominating & Governance, Chair of Compensation. Director Compensation: $100,000 in 2020.
2022-04-29	Michael A. Pietrangelo became a director of the Company in 2010. Since 1998, Mr. Pietrangelo has practiced law and has been of counsel to the firm of Pietrangelo Smith, PLC. Mr. Pietrangelo is admitted to the bars of the states of New York and Tennessee and the District of Columbia. He served on the board of directors of MRI Interventions Inc., a publicly traded research and development company, from 2010 to 2014. More recently, through 2020, Mr. Pietrangelo served as the President and Managing Director of The Theraplex Company, LLC, a privately held skin care company. He brings valuable experience to the Board in corporate governance, legal and financial matters as a result of his positions as a lawyer, executive and director of privately held and public companies, as well as nonprofit organizations. The table below summarizes the compensation paid to our independent directors for the fiscal year ended December 31, 2021. Michael A. Pietrangelo received $100,000 in cash fees in 2021.
2023-04-28	Michael A. Pietrangelo became a director of the Company in 2010. Since 1998, Mr. Pietrangelo has practiced law with, and is now Of Counsel to, the firm of Pietrangelo Smith, PLC. Mr. Pietrangelo is admitted to the bars of the states of New York and Tennessee and the District of Columbia. He served on the board of directors of MRI Interventions Inc., a publicly traded research and development company, from 2010 to 2014. He brings valuable experience to the Board in corporate governance, legal and financial matters as a result of his positions as a lawyer, executive and director of privately held and public companies, as well as nonprofit organizations.
2024-04-26	Michael A. Pietrangelo became a director of the Company in 2010. Since 1998, Mr. Pietrangelo has practiced law and has been of counsel to the firm of Pietrangelo Smith, PLC. Mr. Pietrangelo is admitted to the bars of the states of New York and Tennessee and the District of Columbia. He served on the board of directors of MRI Interventions Inc., a publicly traded research and development company, from 2010 to 2014. More recently, through 2020, Mr. Pietrangelo served as the President and Managing Director of The Theraplex Company, LLC, a privately held skin care company. He brings valuable experience to the Board in corporate governance, legal and financial matters as a result of his positions as a lawyer, executive and director of privately held and public companies, as well as nonprofit organizations.